ACTIVE

V-Bio Fund 2

Financial year 2025 · Closed on 31/12/2025

Net result-2,2 M €-2,9 %over 1 year
Gross margin-2,1 M €-0,7 %over 1 year
Equity51,8 M €+87,1 %over 1 year

Identity

Source · BCE/KBO

V-Bio Fund 2 is a Public limited company incorporated in 2020. Its registered office is in Gent.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0759.685.291
Incorporation
11/12/2020
Legal form
Public limited company
Registered office
Pieter van Reysschootlaan 2 box 104
9051 Gent · FlandreSee on map
Contributed capital
64 501 460,00 €
Latest accounts
31/12/2025
Contacts
2 public details availableLog in to view
Signals
Solid equity

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin-2,1 M €-2,1 M €-2,1 M €-2,5 M €-1,9 M €
EBITDA-2,1 M €-2,1 M €-2,1 M €-2,5 M €-1,9 M €
Operating result-2,2 M €-2,2 M €-2,2 M €-2,5 M €-1,9 M €
Net result-2,2 M €-2,2 M €-3,9 M €-2,5 M €-1,9 M €
Balance sheet
Equity51,8 M €27,7 M €19,2 M €13,1 M €5,6 M €
Total assets51,8 M €28,2 M €19,2 M €13,1 M €5,6 M €
Cash2,7 M €147 k €2,3 M €1,4 M €1,2 M €
Debts–532,4 k €––11,8 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
V-Bio Management 20758.543.760Represented by Christina Takke
MandateDirector11/12/2020 → 2022 accountsended

Other companies at this address

Pieter van Reysschootlaan 2 9051 Gent
CompanyCBE no.
0886.996.605
CD-Vastgoed● Active
0465.063.827
HONEY COMPANY● Active
0793.625.294
1002.228.546
0712.738.182
V-Bio Fund 1● Active
0642.766.540
0641.986.877
0758.543.760
0641.850.186
0758.543.661
V-Bio Ventures● Active
0758.544.057
0839.676.936

Full financial information

Source · NBB
20252024202320222021
Type of accountAbridged modelAbridged modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202211/12/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months13 months
Filing date18/06/202602/06/202526/06/202423/06/202329/12/2022
General meeting26/05/202627/05/202528/05/202430/05/202331/05/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202526/05/202618/06/2026DutchPDF
Abridged model31/12/202427/05/202502/06/2025DutchPDF
Micro model31/12/202328/05/202426/06/2024DutchPDF
Micro model31/12/202230/05/202323/06/2023DutchPDF
Micro model31/12/202131/05/202229/12/2022DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
V-Bio Management 20758.543.760Represented by Christina Takke
MandateDirector11/12/2020 → 2022 accountsended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares20/04/2026
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares15/04/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares13/11/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares28/03/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares28/01/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares15/10/2021
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares10/02/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares18/12/2020
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings5 filings
Mandates
V-Bio Management 2
2020202120222023202420252026
V-Bio Fund 2 Private Privak
Pieter van Reysschootlaan 2 bte 104, 9051 Sint-Denijs-Westrem
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Pieter van Reysschootlaan 2 bte 104, 9051 Sint-Denijs-WestremCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00172893

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
V-Bio Fund 2Current
CBE
V-Bio Fund 2 Private Privak
accounts 2022 → 2025
Accounts 2025 · 2026-00172893
V-Bio Fund 2 NV
accounts 2021
Accounts 2021 · 2022-20548931

Events

  1. 08/04/2026
    augmentation_capital
  2. 2025
    Annual accounts 2025-2,2 M €↓
  3. 10/04/2025
    augmentation_capital
  4. 2024
    Annual accounts 2024-2,2 M €↑
  5. 2023
    Annual accounts 2023-3,9 M €↓
  6. 31/10/2023
    augmentation_capital
  7. 2022
    Annual accounts 2022-2,5 M €↓
  8. 2022
    Name changeV-Bio Fund 2 Private Privak
  9. 2021
    Annual accounts 2021-1,9 M €
  10. 11/12/2020
    IncorporationPublic limited company